The association of antimicrobial resistance with cure and quality of life among women with acute uncomplicated cystitis

Infection

Volumn 39, Issue 6, 2011, Pages 507-514

  Abrahamian, F M ^a,c   Krishnadasan, A ^a   Mower, W R ^c   Moran, G J ^a,b,c   Coker, J R ^a   Talan, D A ^a,b,c  

^a UCLA MEDICAL CENTER   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cystitis; Quality of life; Resistance; TMP SMX; UTI

Indexed keywords

COTRIMOXAZOLE; PHENAZOPYRIDINE;

ABSENTEEISM; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CITROBACTER KOSERI; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DAILY LIFE ACTIVITY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL DISABILITY; PROSPECTIVE STUDY; PROTEUS MIRABILIS; QUALITY OF LIFE; TELEPHONE; TREATMENT OUTCOME; URINALYSIS;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CYSTITIS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; PHENAZOPYRIDINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 82655162189     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0163-z     Document Type: Article

References (19)

1. B Foxman 2002 Epidemiology of urinary tract infections: incidence, morbidity, and economic costs Am J Med 113 5S 13S 12113866 10.1016/S0002- 9343(02)01054-9 (Pubitemid 34756640)
2. TL Griebling 2005 Urologic diseases in America project: trends in resource use for urinary tract infections in women J Urol 173 1281 1287 15758783 10.1097/01.ju.0000155596.98780.82 (Pubitemid 40380555)
3. B Foxman R Barlow H D'Arcy B Gillespie JD Sobel 2000 Urinary tract infection: self-reported incidence and associated costs Ann Epidemiol 10 509 515 11118930 10.1016/S1047-2797(00)00072-7 1:STN:280:DC%2BD3M%2FptlajtA%3D%3D
4. B Foxman RR Frerichs 1985 Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse Am J Public Health 75 1308 1313 4051066 10.2105/AJPH.75.11.1308 1:STN:280:DyaL28%2FitlehtA%3D%3D (Pubitemid 16245022)
5. AK Ellis S Verma 2000 Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract 13 392 397 11117334 1:STN:280:DC%2BD3M7htl2nsQ%3D%3D (Pubitemid 33645637)
6. Gilbert DN, Moellering RC, Jr, Eliopoulos GM, Chambers HF, Saag MS. The Sanford guide to antimicrobial therapy 2010. 40th ed. Sperryville, VA: Antimicrobial Therapy, Inc; 2010. p. 29-31.
7. Y Taur MA Smith 2007 Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection Clin Infect Dis 44 769 774 17304445 10.1086/511866 (Pubitemid 46365298)
8. R Raz B Chazan Y Kennes R Colodner E Rottensterich M Dan I Lavi W Stamm Israeli Urinary Tract Infection Group 2002 Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens Clin Infect Dis 34 1165 1169 11941541 10.1086/339812 1:CAS:528:DC%2BD38XjvFGht7g%3D (Pubitemid 34450662)
9. DA Talan WE Stamm TM Hooton GJ Moran T Burke A Iravani J Reuning-Scherer DA Church 2000 Comparison of ciprofloxacin (7 days) and trimethoprim- sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial JAMA 283 1583 1590 10735395 10.1001/jama.283.12.1583 1:CAS:528:DC%2BD3cXisVehsr4%3D (Pubitemid 30161514)
10. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. CLSI document M100-S15. Wayne, PA: CLSI; 2005.
11. Ware JE Jr, Kosinski M, Dewey JE. How to score version 2 of the SF-36 health survey. Lincoln, RI: Quality Metric Incorporated; 2000.
12. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley; 1981.
13. EJ Ernst ME Ernst JD Hoehns GR Bergus 2005 Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment Health Qual Life Outcomes 3 45 16048650 10.1186/1477-7525-3-45 (Pubitemid 41522145)
14. JA Karlowsky C Thornsberry ME Jones DF Sahm 2003 Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin Clin Infect Dis 36 183 187 12522750 10.1086/345754 1:CAS:528:DC%2BD3sXht1ymsrY%3D (Pubitemid 36143415)
15. CA Czaja D Scholes TM Hooton WE Stamm 2007 Population-based epidemiologic analysis of acute pyelonephritis Clin Infect Dis 45 273 280 17599303 10.1086/519268 (Pubitemid 47101021)
16. DA Talan A Krishnadasan FM Abrahamian WE Stamm GJ Moran EMERGEncy ID NET Study Group 2008 Prevalence and risk factor analysis of trimethoprim- sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis Clin Infect Dis 47 1150 1158 18808361 10.1086/592250
17. JW Warren E Abrutyn JR Hebel JR Johnson AJ Schaeffer WE Stamm 1999 Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA) Clin Infect Dis 29 745 758 10589881 10.1086/520427 1:CAS:528: DyaK1MXnsVWhtLY%3D (Pubitemid 30256361)
18. PD Brown A Freeman B Foxman 2002 Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan Clin Infect Dis 34 1061 1066 11914994 10.1086/339491 1:CAS:528:DC%2BD38XjsFyjsrw%3D (Pubitemid 34289678)
19. RD Hays LS Morales 2001 The RAND-36 measure of health-related quality of life Ann Med 33 350 357 11491194 10.3109/07853890109002089 1:STN:280: DC%2BD3MvksFWqsQ%3D%3D (Pubitemid 32675376)